Park, H., Park, J., Park, H., Kang, K., Jung, K., Kim, B. J., . . . Hong, K. Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial. Korean Stroke Society.
Chicago Style (17th ed.) CitationPark, Hong-Kyun, et al. Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial. Korean Stroke Society.
MLA (9th ed.) CitationPark, Hong-Kyun, et al. Switch to Rosuvastatin Plus Ezetimibe From Statin Monotherapy to Achieve Target LDL-Cholesterol Goal: A Multi-Center, Open-Label, Single-Arm Trial. Korean Stroke Society.
Warning: These citations may not always be 100% accurate.